Hayley Crawford, PhD
Research Scientist
Virology
Integral Molecular
Biography
Hayley Crawford is the Virology Project Leader at Integral Molecular and manages the company’s extensive Reporter Virus Particle (RVP) portfolio. She spearheads all aspects of the SARS-CoV-2 RVP product cycle—from product development through manufacturing and quality control—for current and emerging strains. Prior to joining Integral Molecular, Dr. Crawford was a postdoctoral researcher at Oxford University, where she worked on designing HIV vaccines using CD8+ T cell epitope constructs. She obtained her PhD from Oxford University and has over a decade of experience in virology and immunology.